Results 121 to 130 of about 60,894 (286)

Clinical and bacteriological characteristics of invasive pneumococcal disease after pneumococcal 10-valent conjugate vaccine implementation in Salvador, Brazil

open access: yesBrazilian Journal of Infectious Diseases, 2016
Invasive pneumococcal disease is a relevant public health problem in Brazil, especially among children and the elderly. In July/2010 a 10-valent pneumococcal conjugate vaccine was introduced to the immunization schedule of Brazilian children under two ...
Carolina Regis Leite   +5 more
doaj  

IMMUNOGENICITY OF A PNEUMOCOCCAL PROTEIN CONJUGATE VACCINE IN INFANTS WITH SICKLE CELL DISEASE. ▴ 946 [PDF]

open access: bronze, 1996
Katherine L. O’Brien   +10 more
openalex   +1 more source

EVALUATION OF A PENTAVALENT CONJUGATED PNEUMOCOCCAL VACCINE IN TODDLERS.▴ 1077 [PDF]

open access: bronze, 1996
Michael E. Pichichero   +2 more
openalex   +1 more source

Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage Among American Indians

open access: yesThe Pediatric Infectious Disease Journal, 2016
Background: Community-wide impact of pneumococcal conjugate vaccines (PCV) is conferred by reductions in vaccine-type nasopharyngeal carriage. We evaluated the impact of PCV13 on carriage of PCV13-specific types (1, 3, 5, 6A, 7F and 19A) and 6C among ...
L. Grant   +8 more
semanticscholar   +1 more source

Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children

open access: yesJournal of Immunology Research, 2015
Applications of the heptavalent pneumococcal conjugate vaccine (PCV7) in the pediatric immunization schedule have dramatically reduced the incidence of pneumococcal diseases in both vaccinated children and unvaccinated individuals of all ages.
Susanna Esposito, Nicola Principi
doaj   +1 more source

The Effect of 13-Valent Pneumococcal Conjugate Vaccine on the Serotype Distribution and Antibiotic Resistance Profiles in Children With Invasive Pneumococcal Disease

open access: yesJournal of the Pediatric Infectious Diseases Society, 2016
Background Invasive pneumococcal disease (IPD) continues to be a significant burden in children despite the implementation of two generations of conjugate vaccines.
Claudia Gaviria-Agudelo   +3 more
semanticscholar   +1 more source

SAFETY AND IMMUNOGENICITY OF TWO LOTS OF PNEUMOCOCCAL CONJUGATE VACCINE IN INFANTS. ▴ 1116 [PDF]

open access: bronze, 1996
Kenneth M. Zangwill   +5 more
openalex   +1 more source

The multifaceted impact of pneumococcal conjugate vaccine implementation in children in France between 2001 to 2014

open access: yesHuman Vaccines & Immunotherapeutics, 2016
In 2003, France was the first European country to recommend 7-valent pneumococcal conjugate vaccine (PCV7) for a large proportion of healthy children. With complicated recommendations, the vaccine coverage during the first 4 y of implementation was low ...
R. Cohen, S. Biscardi, C. Levy
semanticscholar   +1 more source

Overall effectiveness of pneumococcal conjugate vaccines: An economic analysis of PHiD-CV and PCV-13 in the immunization of infants in Italy

open access: yesHuman Vaccines & Immunotherapeutics, 2017
Pneumococcal diseases are associated with a significant clinical and economic burden. The 7-valent pneumococcal conjugate vaccine (PCV-7) has been used for the immunization of newborns against invasive pneumococcal diseases (IPD) in Italy while now, the ...
Paolo Castiglia   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy